Crescent Biopharma, Inc. (CBIO)
NASDAQ: CBIO · Real-Time Price · USD
9.79
+0.20 (2.09%)
Feb 2, 2026, 4:00 PM EST - Market closed
Crescent Biopharma Market Cap
Crescent Biopharma has a market cap or net worth of $192.17 million as of February 2, 2026.
Market Cap
192.17M
Enterprise Value
192.64M
1-Year Change
n/a
Ranking
Category
Stock Price
$9.79
Market Cap Chart
Since June 16, 2025, Crescent Biopharma's market cap has decreased from $308.79M to $192.17M, a decrease of -37.77%. That is a compound annual growth rate of -53.20%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 30, 2026 | 187.48M | -19.14% |
| Dec 31, 2025 | 231.86M | -24.91% |
| Jun 16, 2025 | 308.79M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Milestone Pharmaceuticals | 194.02M |
| Tharimmune | 193.30M |
| Tiziana Life Sciences | 192.71M |
| Humacyte | 192.55M |
| Camp4 Therapeutics | 191.96M |
| Protalix BioTherapeutics | 188.19M |
| Surrozen | 184.67M |
| Sagimet Biosciences | 184.40M |